多原发性肺癌1例报告并文献复习
A Case Report of Multiple Primary Lung Cancer and Literature Review
DOI: 10.12677/acm.2026.1641297, PDF,   
作者: 李兵臣:济宁医学院临床医学院,山东 济宁;崔红霞*:济宁市第一人民医院肿瘤科,山东 济宁
关键词: 多原发性肺癌同步性病理类型诊断治疗Multiple Primary Lung Cancer Synchronous Pathological Type Diagnosis Treatment
摘要: 多原发性肺癌(MPLC)是临床罕见的肺癌类型,指单肺或双肺不同部位发生两个及以上独立起源的原发肺癌,按发病时间分为同步性和异时性,其诊断标准历经多次优化但尚未形成统一共识,且不同病理类型共存的MPLC临床报道尤为稀缺。本文报道1例62岁男性同步性多原发性肺癌患者,该患者同时确诊右肺腺癌、左肺上叶鳞状上皮原位癌、左肺下叶小细胞癌三种病理类型,为临床罕见病例。结合该病例的临床资料、诊疗过程,并查阅国内外相关文献,对MPLC的发病率、诊断方法、发病机制、预后影响因素及治疗策略进行叙述性文献回顾,旨在提高临床医师对MPLC的认知水平,为这类罕见病例的早期诊断、个体化治疗提供参考依据,减少临床漏诊、误诊情况的发生。
Abstract: Multiple primary lung cancer (MPLC) is a rare clinical type of lung cancer, referring to two or more primary lung cancers with independent origins occurring in different parts of a single lung or both lungs. It is divided into synchronous and metachronous types according to the onset time. Its diagnostic criteria have been optimized for many times but no unified consensus has been formed, and clinical reports of MPLC with coexisting different pathological types are particularly scarce. This paper reports a 62-year-old male patient with synchronous multiple primary lung cancer, who was diagnosed with three pathological types including right lung adenocarcinoma, squamous cell carcinoma in situ of the left upper lung and small cell carcinoma of the left lower lung at the same time, which is a rare clinical case. Combined with the clinical data and diagnosis and treatment process of this case, and by reviewing the relevant domestic and foreign literature, this paper systematically summarizes the incidence, diagnostic methods, pathogenesis, prognostic factors and treatment strategies of MPLC, aiming to improve clinicians’ cognitive level of MPLC, provide reference for early diagnosis and individualized treatment of such rare cases, and reduce the occurrence of clinical missed diagnosis and misdiagnosis.
文章引用:李兵臣, 崔红霞. 多原发性肺癌1例报告并文献复习[J]. 临床医学进展, 2026, 16(4): 698-704. https://doi.org/10.12677/acm.2026.1641297

参考文献

[1] Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A. (2023) Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17-48. [Google Scholar] [CrossRef] [PubMed]
[2] Dong, H., Tian, Y., Xin, S., Jiang, S., Guo, Y., Wan, Z., et al. (2024) Diagnosis and Management of Multiple Primary Lung Cancer. Frontiers in Oncology, 14, Article 1392969. [Google Scholar] [CrossRef] [PubMed]
[3] Martini, N. and Melamed, M.R. (1975) Multiple primary lung cancers. The Journal of Thoracic and Cardiovascular Surgery, 70, 606-612. [Google Scholar] [CrossRef
[4] Kozower, B.D., Larner, J.M., Detterbeck, F.C. and Jones, D.R. (2013) Special Treatment Issues in Non-Small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 143, e369S-e399S. [Google Scholar] [CrossRef] [PubMed]
[5] Detterbeck, F.C., Nicholson, A.G., Franklin, W.A., Marom, E.M., Travis, W.D., Girard, N., et al. (2016) The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification. Journal of Thoracic Oncology, 11, 639-650. [Google Scholar] [CrossRef] [PubMed]
[6] Amin, M.B., Greene, F.L., Edge, S.B., Compton, C.C., Gershenwald, J.E., Brookland, R.K., et al. (2017) The Eighth Edition AJCC Cancer Staging Manual: Continuing to Build a Bridge from a Population‐Based to a More “Personalized” Approach to Cancer Staging. CA: A Cancer Journal for Clinicians, 67, 93-99. [Google Scholar] [CrossRef] [PubMed]
[7] Chiang, C., Tsai, P., Yeh, Y., Wu, Y., Hsu, H. and Chen, Y. (2022) Recent Advances in the Diagnosis and Management of Multiple Primary Lung Cancer. Cancers, 14, Article 242. [Google Scholar] [CrossRef] [PubMed]
[8] Stirpe, E., Bardaro, F. and Koehl, J. (2023) Synchronous Lung Cancer Presenting with Small Cell Carcinoma and Squamous Cell Lung Carcinoma: A Case Report. Monaldi Archives for Chest Disease, 94, Article 2748. [Google Scholar] [CrossRef] [PubMed]
[9] Tian, H., Bai, G., Yang, Z., Chen, P., Xu, J., Liu, T., et al. (2023) Multiple Primary Lung Cancer: Updates of Clinical Management and Genomic Features. Frontiers in Oncology, 13, Article 1034752. [Google Scholar] [CrossRef] [PubMed]
[10] Li, Z., Lv, H., Zhang, F., Zhu, Z., Guo, Q., Wang, M., et al. (2024) Using Molecular Characteristics to Distinguish Multiple Primary Lung Cancers and Intrapulmonary Metastases. PeerJ, 12, e16808. [Google Scholar] [CrossRef] [PubMed]
[11] Goodwin, D., Rathi, V., Conron, M. and Wright, G.M. (2021) Genomic and Clinical Significance of Multiple Primary Lung Cancers as Determined by Next-Generation Sequencing. Journal of Thoracic Oncology, 16, 1166-1175. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, C., Yin, K., Liu, S., Yan, L., Su, J., Wu, Y., et al. (2021) Multiomics Analysis Reveals a Distinct Response Mechanism in Multiple Primary Lung Adenocarcinoma after Neoadjuvant Immunotherapy. Journal for ImmunoTherapy of Cancer, 9, e002312. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, T., Yang, L., Chen, H., Zhou, Z., Wu, Z., Luo, H., et al. (2023) A Pairwise Radiomics Algorithm-Lesion Pair Relation Estimation Model for Distinguishing Multiple Primary Lung Cancer from Intrapulmonary Metastasis. Precision Clinical Medicine, 6, pbad029. [Google Scholar] [CrossRef] [PubMed]
[14] Chen, Y., He, M., Dai, Z., Wang, Y., Chen, J., Wang, X., et al. (2023) Clinical and Molecular Profiling of EGFR-Mutant Lung Adenocarcinomas Transformation to Small Cell Lung Cancer during TKI Treatment. Frontiers in Oncology, 13, Article 1308313. [Google Scholar] [CrossRef] [PubMed]
[15] Yu, L., Bazhenova, L., Gold, K., Tran, L., Hilburn, V., Vu, P., et al. (2022) Clinicopathologic and Molecular Characteristics of EGFR-Mutant Lung Adenocarcinomas That Transform to Small Cell Lung Cancer after TKI Therapy. Translational Lung Cancer Research, 11, 452-461. [Google Scholar] [CrossRef] [PubMed]
[16] Meador, C.B. and Piotrowska, Z. (2023) Biology and Impact of Lineage Plasticity in Alk-Positive NSCLC: A Narrative Review. Translational Lung Cancer Research, 12, 837-856. [Google Scholar] [CrossRef] [PubMed]
[17] Huo, J., Luo, T., He, X., Gong, J., Lv, F. and Li, Q. (2022) Radiological Classification, Gene-Mutation Status, and Surgical Prognosis of Synchronous Multiple Primary Lung Cancer. European Radiology, 32, 4264-4274. [Google Scholar] [CrossRef] [PubMed]
[18] Shintani, Y., Okami, J., Ito, H., Ohtsuka, T., Toyooka, S., Mori, T., et al. (2021) Clinical Features and Outcomes of Patients with Stage I Multiple Primary Lung Cancers. Cancer Science, 112, 1924-1935. [Google Scholar] [CrossRef] [PubMed]
[19] Zhang, H., Liu, Q., Chen, L., Song, L., Mao, F., Zhou, W., et al. (2024) Identification of the Prognostic Factors for Synchronous Multiple Primary Lung Cancer Treated with Staged Bilateral Surgery. The Clinical Respiratory Journal, 18, e70017. [Google Scholar] [CrossRef] [PubMed]
[20] Videtic, G.M.M., Donington, J., Giuliani, M., Heinzerling, J., Karas, T.Z., Kelsey, C.R., et al. (2017) Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Practical Radiation Oncology, 7, 295-301. [Google Scholar] [CrossRef] [PubMed]
[21] Chang, J.Y., Liu, Y., Zhu, Z., Welsh, J.W., Gomez, D.R., Komaki, R., et al. (2013) Stereotactic Ablative Radiotherapy: A Potentially Curable Approach to Early Stage Multiple Primary Lung Cancer. Cancer, 119, 3402-3410. [Google Scholar] [CrossRef] [PubMed]
[22] Nikitas, J., DeWees, T., Rehman, S., Abraham, C., Bradley, J., Robinson, C., et al. (2019) Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers. Clinical Lung Cancer, 20, 107-116. [Google Scholar] [CrossRef] [PubMed]